In this issue:
Dolutegravir shows good tolerability in 3-drug PEP but is linked to CNS AEs in retrospective data
Impact of CDC HIV PrEP guidelines for MSM
Drug resistance with INSTI-based ART
Multidrug-resistant HIV-1 infection despite PrEP
Improving adherence to ART
Risk compensation after HIV
PrEP among MSM
Immediate ART reduces risk of severe bacterial infections and improves QOL
Preventing transmitted INSTI resistance
Please login below to download this issue (PDF)